- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Acetate kinase.
Displaying page 1 of 1.
EudraCT Number: 2016-003752-79 | Sponsor Protocol Number: PIONEER | Start Date*: 2017-05-24 | |||||||||||
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust and University of Cambridge | |||||||||||||
Full Title: Randomised Phase II clinical trial PIONEER- A Pre-operative wIndOw study of letrozole plus PR agonist (Megestrol Acetate) versus letrozole aloNE in post-menopausal patients with ER-positive breast ... | |||||||||||||
Medical condition: ER-positive, HER2-negative, invasive primary breast cancer of at least 1 cm size | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003011-46 | Sponsor Protocol Number: ASOKLIF 0603/ST | Start Date*: 2006-09-06 |
Sponsor Name:Dr. Olaf Stanger | ||
Full Title: Klinische Studie zur Überprüfung des Stellenwerts einer perioperativen Verabreichung der Vitamine E und C und/oder von Omega-3-Fettsäuren bei der Verminderung des Reperfusionsschadens nach Herzoper... | ||
Medical condition: aortokoronare Bypassoperation bei einer geschätzten Dauer der extrakorporalen Zirkulation (EKZ) zwischen 20 und 60 Minuten | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001072-21 | Sponsor Protocol Number: MKN106762 | Start Date*: 2006-08-08 |
Sponsor Name:GlaxoSmithKline Research and Development Ltd | ||
Full Title: A double-blind placebo-controlled study of the efficacy and safety of the P38 Map Kinase inhibitor SB681323 in patients with neuropathic pain following nerve trauma | ||
Medical condition: Neuropathic pain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-001219-22 | Sponsor Protocol Number: PGL11-021 | Start Date*: 2012-06-11 | ||||||||||||||||
Sponsor Name:PregLem S.A. | ||||||||||||||||||
Full Title: A Phase IIa study investigating the efficacy and safety of the c-Jun-N-Terminal Kinase (JNK) inhibitor PGL5001 versus placebo administered for up to 5 months with concomitant administration of depo... | ||||||||||||||||||
Medical condition: Peritoneal and/or ovarian endometriosis with an inflammatory component. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: PL (Completed) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
